Home » pre clinical

Iris Pharma is a French Contract Research Organization (CRO) dedicated to pre-clinical studies, (non-clinical research) in ophthalmology.

Founded in 1989 by Pierre-Paul Elena, Ph.D., Iris Pharma provides drug development services to Biotechnology and Pharmaceutical Industries, and Institutes. The company works in five complementary areas using the latest apparatus: bioanalysis; non-GLP pre-clinical formulation; pre-clinical studies and services; clinical trials (Phase I to IV); and strategic consulting.

Pre-clinical studies and in-depth research

Our French Contract Research Organization provides efficient pre-clinical studies and animal models of Ocular Angiogenesis :

• Corneal angiogenesis pre-clinical studies: sutures or alkali burn
• Retinal angiogenesis pre-clinical studies : animal model of oxygen-induced retinopathy (OIR)
• Choroidal neovascularization: experimental argon laser-induced CNV (choroidal neovascularization)
• Retinal Vascular permeability pre-clinical studies: VEGF-induced fluorescein leakage

Pre-clinical studies and a complete range of services

Iris Pharma's Research Department never stops exploring: pre-clinical studies in ophthalmology, studies related to glaucoma, pharmacokinetic studies, retinopathy research, ocular drug efficacy studies etc.